PureTech-linked Seaport Therapeutics reports positive Phase 1 results
PureTech Health says Seaport Therapeutics has reported positive Phase 1 driving trial results for GlyphAllo.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.